Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China

PHASE4CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Pulmonary EmbolismThromboembolism
Interventions
DRUG

rt-PA

rt-PA 100 mg continuous intravenous infusion for 2 hours

DRUG

rt-PA

rt-PA 50 mg continuous intravenous infusion for 2 hours

Trial Locations (23)

100020

Beijing Chaoyang Hospital, Capital University of Medical Sciences, Beijing

Unknown

Beijing University People's Hospital, Beijing

Peking Union Hospital, Chinese Academy of Medical Sciences, Beijing

The Omni-hospital of Air-force, Beijing

Shenzhen People's Hospital, Shenzhen

The First Affiliated Hospital of Guangxi Medical University, Nanning

Guangzhou Institute of Respiratory Disease, Guangdong

The Second Affiliated Hospital of Hebei University, Shijiazhuang

The First Affiliated Hospital of Zhengzhou University:, Zhengzhou

Shenyang Military Hospital, Shenyang

The Affiliated Hospital of Shenyang Medical University, Shenyang

The Affiliated Hospital of Ningxia Medical University, Yinchuang

Shangdong Yantaishan Hospital, Yantai

Qilu Hospital of Shandong University, Jinan

The First Affiliated Hospital of Jining Medical College, Jinan

The First Affiliated Hospital of Qingdao University CHENG Zhao-zhong, Qingdao

Shanghai Hospital of Lung Disease, Shanghai

Shanghai Ruijin Hospital HUANG Shao-guang, Shanghai

The First Affiliated Hospital of Shanxi University, Taiyuan

The Second Affiliated Hospital of Shanxi University, Taiyuan

Tianjin Hospital of Medical Sciences, Tianjin

The Affiliated Hospital of Wenzhou Medical College, Wenzhou

Zhejiang Shaoyifu Hospital, Hangzhou

All Listed Sponsors
lead

Beijing Chao Yang Hospital

OTHER

NCT00781378 - Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China | Biotech Hunter | Biotech Hunter